Characterizing the vaginal microbiome in patients with high grade cervical dysplasia

被引：0
|
作者：
Kuan-Celarier, Anna [1 ]
Jacobson, Dave [2 ]
Honap, Tanvi Prasad [2 ]
Wilkerson, Marielle [1 ]
Patel, Hima [2 ]
Moore, Kathleen [2 ]
Lewis, Cecil M. [2 ]
机构：
[1] Univ Oklahoma, Hlth Sci Ctr, Oklahoma City, OK USA
[2] Univ Oklahoma, Oklahoma City, CA USA
来源：
GYNECOLOGIC ONCOLOGY | 2022年 / 166卷
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
277
引用
收藏
页码：S147 / S148
页数：2
相关论文
共 50 条
  • [1] PANDA: A prospective study of the prevalence of anal dysplasia among women with high-grade cervical, vaginal, and vulvar dysplasia or cancer
    Batman, Samantha
    Messick, Craig
    Milbourne, Andrea
    Guo, Ming
    Munsell, Mark
    Domgue, Joel Fokom
    Salcedo, Mila
    Deshmukh, Ashish
    Dahlstrom, Kristina
    Ogburn, Mallory
    Sigel, Keith
    Sturgis, Erich
    Chiao, Elizabeth
    Schmeler, Kathleen
    GYNECOLOGIC ONCOLOGY, 2022, 166 : S71 - S71
  • [2] The vaginal microbiome as a mediator in the relationship between Black/White race and high grade cervical intraepithelial neoplasia
    Tossas, Katherine Y.
    Sullivan, Stephanie
    Serrano, Myrna
    Strauss, Jerome
    Winn, Robert A.
    Buck, Gregory
    CANCER RESEARCH, 2023, 83 (07)
  • [3] Adherence to Management Recommendations in Patients Diagnosed With High-Grade Cervical Dysplasia
    Scaparotti, Alexis Camille
    Alston, Meredith Johnson
    Krull, Mona
    Mazzoni, Sara Elizabeth
    OBSTETRICS AND GYNECOLOGY, 2015, 125 : 13S - 13S
  • [4] Vaginal microbiome and cervical cancer
    Kyrgiou, Maria
    Moscicki, Anna-Barbara
    SEMINARS IN CANCER BIOLOGY, 2022, 86 : 189 - 198
  • [5] Mechanisms of immune privilege in high grade cervical dysplasia
    Trimble, Cornelia
    Thoburn, Christopher
    Kos, Ferdynand
    Peng, Shiwen
    Viscidi, Raphael
    Gravitt, Patti
    Roden, Richard
    Wu, Tzyy-Choou
    Pardoll, Drew
    Sugar, Elizabeth
    Jungbluth, Achim
    CLINICAL IMMUNOLOGY, 2008, 127 : S156 - S156
  • [6] Descriptive study of the vaginal microbiome in Hispanic populations in Houston and Puerto Rico with high-risk normal and cervical dysplasia
    Walters, D'Shaunique
    El Alam, Molly
    Harris, Timothy
    Cisneros, Tatiana
    Ajami, Nadim
    Sastry, Jagannadha
    Romaguera, Josefina
    Godoy-Vitorino, Filipa
    Dorta-Estremera, Stephanie
    Klopp, Ann
    Colbert, Lauren
    CANCER EPIDEMIOLOGY BIOMARKERS & PREVENTION, 2024, 33 (09)
  • [7] CHARACTERIZING THE VAGINAL MICROBIOME OF GYNECOLOGIC CANCER PATIENTS: AN INTEGRATIVE REVIEW.
    Lemen, Julie
    Bruner, Deborah
    ONCOLOGY NURSING FORUM, 2016, 43 (02) : 61 - 62
  • [8] Vaginal progesterone in the treatment of cervical dysplasia grade I: A phase II trial.
    Hefter, LA
    Grimm, C
    Six, L
    Sliutz, G
    Reinthaller, A
    JOURNAL OF CLINICAL ONCOLOGY, 2005, 23 (16) : 497S - 497S
  • [9] DOES VAGINAL MICROBIOME COMPOSITION ALTER LOCAL CANCER BIOMARKER EXPRESSION IN CERVICAL DYSPLASIA AND CANCER?
    Laniewski, P.
    Barnes, D.
    Goulder, A.
    Cui, H.
    Monk, B.
    Greenspan, D.
    Roe, D.
    Chase, D.
    Herbst-Kralovetz, M.
    INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER, 2018, 28 : 157 - 157
  • [10] Vaginal 5-fluorouracil for high-grade cervical dysplasia in human immunodeficiency virus infection: A randomized trial
    Maiman, M
    Watts, DH
    Andersen, J
    Clax, P
    Merino, M
    Kendall, MA
    OBSTETRICS AND GYNECOLOGY, 1999, 94 (06): : 954 - 961
12345